Institutional Ownership Fennec Pharmaceuticals Inc. (FENC)
This table provides information about the institutional ownership of Fennec Pharmaceuticals Inc. (FENC). We have compiled data on the 64 institutions that hold shares in the stock, with a total of 14.9 Million shares, which have been reported (via 13F filing form) to have a value of $63.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Southpoint Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
4,077,214
shares
|
$18.9 Million
0.57% of portfolio
|
Q2 2020
Added 2.0%
|
|
Sonic Gp LLC
Honolulu, HI |
Nov 14, 2024 Q3 2024 |
2,407,357
shares
|
$11.2 Million
27.51% of portfolio
|
Q4 2022
New holding
|
|
Solas Capital Management, LLC
Darien, CT |
Nov 14, 2024 Q3 2024 |
1,923,536
shares
|
$8.93 Million
7.68% of portfolio
|
Q3 2024
Added 43.55%
|
|
Dg Capital Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
1,522,204
shares
|
$7.06 Million
4.41% of portfolio
|
Q3 2024
Reduced 6.89%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,187,242
shares
|
$5.51 Million
0.0% of portfolio
|
Q2 2024
Added 28.01%
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
1,047,891
shares
|
$4.86 Million
0.0% of portfolio
|
Q3 2024
Added 2.07%
|
|
Harbert Fund Advisors, Inc.
Birmingham, AL |
Nov 13, 2024 Q3 2024 |
466,869
shares
|
$2.17 Million
1.38% of portfolio
|
Q1 2024
New holding
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
328,259
shares
|
$1.52 Million
0.0% of portfolio
|
Q3 2024
Added 2.2%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
299,298
shares
|
$1.39 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.76%
|
|
Gendell Jeffrey L
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
231,841
shares
|
$1.08 Million
0.04% of portfolio
|
Q3 2024
Reduced 18.18%
|
|
Lion Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
215,000
shares
|
$997,599
2.89% of portfolio
|
Q3 2024
Added 26.47%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
148,462
shares
|
$688,863
0.0% of portfolio
|
Q3 2024
Added 45.43%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
139,731
shares
|
$648,351
0.0% of portfolio
|
Q3 2024
Added 31.33%
|
|
Winton Group LTD
London, X0 |
Nov 12, 2024 Q3 2024 |
71,656
shares
|
$332,483
0.03% of portfolio
|
Q3 2024
Added 6.94%
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2024 Q3 2024 |
59,817
shares
|
$277,550
0.0% of portfolio
|
Q3 2024
Added 12.21%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
55,452
shares
|
$257,297
0.0% of portfolio
|
Q2 2024
Added 33.63%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
53,753
shares
|
$249,413
0.0% of portfolio
|
Q3 2024
Added 166.98%
|
|
Advantage Alpha Capital Partners LP
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
52,876
shares
|
$245,344
0.06% of portfolio
|
Q3 2024
New holding
|
|
Hartford Financial Management Inc.
|
Oct 28, 2024 Q3 2024 |
48,848
shares
|
$226,654
0.05% of portfolio
|
Q2 2024
Added 2.2%
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
48,714
shares
|
$226,032
0.0% of portfolio
|
Q3 2024
Added 3.68%
|
|
Eudaimonia Advisors LLC
Winchester, TN |
Apr 25, 2024 Q1 2024 |
35,359
shares
|
$164,065
0.21% of portfolio
|
Q1 2024
Added 8.18%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
34,539
shares
|
$160,260
0.0% of portfolio
|
Q3 2022
New holding
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
31,319
shares
|
$145,320
0.0% of portfolio
|
Q3 2024
Added 274.27%
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
30,388
shares
|
$141,000
0.0% of portfolio
|
Q3 2024
Added 4.39%
|
|
Sherbrooke Park Advisers LLC
White Plains, NY |
Nov 14, 2024 Q3 2024 |
29,630
shares
|
$137,483
0.03% of portfolio
|
Q3 2024
Added 4.44%
|